What is MNMD stock price today?

MNMD (Mind Medicine (Mindmed) Inc) stock is trading at $16.78 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MNMD stock going up or down today?

MNMD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MNMD stock now?

The decision to buy MNMD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MNMD a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MNMD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MNMD stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MNMD is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MNMD's P/E ratio?

P/E ratio data for MNMD will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MNMD's market cap?

MNMD (Mind Medicine (Mindmed) Inc) has a market capitalization of $1.46 billion, making it a small-cap stock.

What is MNMD's price to book ratio?

MNMD trades at a price-to-book (P/B) ratio of 11.35, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MNMD pay dividends?

MNMD does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MNMD's dividend yield?

MNMD does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MNMD stock a good long-term investment?

MNMD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MNMD's revenue growth rate?

Revenue growth data for MNMD is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MNMD are available on our dashboard with complete income statement analysis.

What are the risks of investing in MNMD?

Key risks for MNMD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MNMD compare to its competitors?

Compare MNMD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MNMD's performance and positioning.

What is MNMD's stock price target for 2026?

Our AI model provides price targets for MNMD based on fundamental analysis: Bull case $21.81 (+30%), Base case $19.30 (+15%), Bear case $15.10 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MNMD?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MNMD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MNMD's next earnings report?

MNMD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MNMD - Mind Medicine (Mindmed) Inc

NYSE * Health Care * Biotechnology

$16.78

+$1.40 (+9.10%)

About Mind Medicine (Mindmed) Inc

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.

MNMD Key Statistics

Market Cap

$1.46B

P/B Ratio

11.35

EPS

$-1.98

Employees

How MNMD Compares to Peers

MNMD is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MNMD(This stock)	$1.46B	N/A	0%	0.0%	-
AMGNAmgen Inc	$177.92B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.99B	19.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.16B	31.1	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.69B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.26B	15.1	0%	0.2%	vs BIIB

Mind Medicine (Mindmed) Inc Company Information

Headquarters: British Columbia; Canada
Website: www.mindmed.co
Sector: Health Care
Industry: Biotechnology

Data Updated: January 21, 2026 at 1:37 AM EST

Ready to invest in MNMD?

Commission-free trading available. Affiliate links.

MNMD Lician Score

5% confidence

4.0/10

Neutral

MNMD has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates MNMDacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

MNMD Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for MNMD

Dashboard

Enter a ticker to analyze